Home > Back to Publisher > Report Information

The World Market for Vaccines, Antisera, and Other Blood Fractions: A 2004 Global Trade Perspective

Icon Group International, Inc.
June 3, 2003
156 Pages - SKU: ICN918105

Abstract Table of Contents Search inside this report Related Reports

Countries covered: Global

The World Market for Vaccines, Antisera, and Other Blood Fractions: A 2004 Global Trade Perspective

This report was created for strategic planners, international executives and import/export managers who are concerned with the market for vaccines, antisera, and other blood fractions. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. I have developed a methodology, based on macroeconomic and trade models, to estimate the market for vaccines, antisera, and other blood fractions for those countries serving the world market via exports or supplying from various countries via imports. I do so for the current year based on a variety of key historical indicators and econometric models.

Excerpt: On the demand side, exporters and strategic planners approaching the world market face a number of questions. Which countries are supplying vaccines, antisera, and other blood fractions? What is the dollar value of these imports? How much do the imports of vaccines, antisera, and other blood fractions vary from one country to another? Do exporters serving the world market have similar market shares across the importing countries? Which countries supply the most exports of vaccines, antisera, and other blood fractions? Which countries are buying their exports? What is the value of these exports and which countries are the largest buyers?

In what follows, Chapter 2 begins by summarizing the regional markets for imported and exported vaccines, antisera, and other blood fractions. The total level of imports and exports on a worldwide basis, and those for each region, is based on a model which aggregates across country markets and projects these to the current year. From there, each country represents a percent of the world market. This market is served from a number of competitive countries of origin. Based on both demand- and supply-side dynamics, market shares by country of origin are then calculated across each country market destination. These shares lead to a volume of import and export values for each country and are aggregated to regional and world totals. In doing so, we are able to obtain maximum likelihood estimates of both the value of each market and the shares that countries are likely to receive this year. From these figures, rankings are calculated to allow managers to prioritize markets. In this way, all the figures provided in this report are forecasts that can be combined with internal information for strategic planning purposes.

After the worldwide summary in Chapter 2 of both imports and exports, Chapter 3 details the exports of vaccines, antisera, and other blood fractions, for each individual country. Chapter 4 does the same, but for imports of vaccines, antisera, and other blood fractions for all countries in the world. In all cases, the total dollar volume and percentage share values by major trading partner are provided. Combined, Chapters 3 and 4 present the complete picture for imports and exports of vaccines, antisera, and other blood fractions to and from all major countries in the world. Of the countries considered, if a country is not reported here it is therefore estimated to have only a negligible level of trade in vaccines, antisera, and other blood fractions (i.e. their market shares are close or equal to zero percent). "Vaccines, Antisera, and Other Blood Fractions" as a category is defined in this report following the definition given by the United Nations Statistics Division Classification Registry using the Standard International Trade Classification, Revision 3 (SITC, Rev. 3). The SITC code that defined "vaccines, antisera, and other blood fractions" is 54163.

1   METHODOLOGY
1.1   Our Approach
2   THE WORLD MARKET
2.1   Exports
2.1.1   The World Market: Exports in 2004
2.2   Imports
2.2.1   The World Market: Imports in 2004
3   EXPORTS
3.1   Africa: Export Supplies in 2004
3.1.1   Executive Summary
3.1.2   Botswana
3.1.3   Cameroon
3.1.4   Djibouti
3.1.5   Egypt
3.1.6   Kenya
3.1.7   Morocco
3.1.8   Senegal
3.1.9   South Africa
3.1.10   Uganda
3.2   Asia: Export Supplies in 2004
3.2.1   Executive Summary
3.2.2   Brunei
3.2.3   China
3.2.4   Hong Kong
3.2.5   India
3.2.6   Indonesia
3.2.7   Japan
3.2.8   Malaysia
3.2.9   North Korea
3.2.10   Singapore
3.2.11   South Korea
3.2.12   Taiwan
3.2.13   Thailand
3.3   Europe: Export Supplies in 2004
3.3.1   Executive Summary
3.3.2   Albania
3.3.3   Austria
3.3.4   Belgium
3.3.5   Bulgaria
3.3.6   Croatia
3.3.7   Cyprus
3.3.8   Czech Republic
3.3.9   Denmark
3.3.10   Estonia
3.3.11   Finland
3.3.12   France
3.3.13   Germany
3.3.14   Greece
3.3.15   Hungary
3.3.16   Ireland
3.3.17   Italy
3.3.18   Latvia
3.3.19   Lithuania
3.3.20   Macedonia
3.3.21   Malta
3.3.22   Netherlands
3.3.23   Norway
3.3.24   Poland
3.3.25   Portugal
3.3.26   Romania
3.3.27   Russia
3.3.28   Serbia & Montenegro
3.3.29   Slovakia
3.3.30   Slovenia
3.3.31   Spain
3.3.32   Sweden
3.3.33   Switzerland
3.3.34   Ukraine
3.3.35   United Kingdom
3.4   Latin America: Export Supplies in 2004
3.4.1   Executive Summary
3.4.2   Argentina
3.4.3   Belize
3.4.4   Brazil
3.4.5   Chile
3.4.6   Colombia
3.4.7   Costa Rica
3.4.8   Ecuador
3.4.9   El Salvador
3.4.10   Guatemala
3.4.11   Honduras
3.4.12   Mexico
3.4.13   Nicaragua
3.4.14   Panama
3.4.15   Paraguay
3.4.16   Peru
3.4.17   Uruguay
3.4.18   Venezuela
3.5   N. America & Caribbean: Export Supplies in 2004
3.5.1   Executive Summary
3.5.2   Aruba
3.5.3   Canada
3.5.4   Cuba
3.5.5   United States
3.6   Oceana: Export Supplies in 2004
3.6.1   Executive Summary
3.6.2   Australia
3.6.3   New Zealand
3.7   The Middle East: Export Supplies in 2004
3.7.1   Executive Summary
3.7.2   Armenia
3.7.3   Iran
3.7.4   Israel
3.7.5   Jordan
3.7.6   Kyrgyzstan
3.7.7   Pakistan
3.7.8   Saudi Arabia
3.7.9   Turkey
3.7.10   United Arab Emirates
4   IMPORTS
4.1   Africa: Imports in 2004
4.1.1   Executive Summary
4.1.2   Algeria
4.1.3   Burundi
4.1.4   Ethiopia
4.1.5   Ghana
4.1.6   Guinea
4.1.7   Ivory coast
4.1.8   Kenya
4.1.9   Mauritius
4.1.10   Morocco
4.1.11   Nigeria
4.1.12   Senegal
4.1.13   South Africa
4.1.14   Tunisia
4.1.15   Uganda
4.2   Asia: Imports in 2004
4.2.1   Executive Summary
4.2.2   China
4.2.3   Hong Kong
4.2.4   Indonesia
4.2.5   Japan
4.2.6   Macau
4.2.7   Malaysia
4.2.8   Papua New Guinea
4.2.9   Philippines
4.2.10   Singapore
4.2.11   South Korea
4.2.12   Thailand
4.3   Europe: Imports in 2004
4.3.1   Executive Summary
4.3.2   Albania
4.3.3   Austria
4.3.4   Belarus
4.3.5   Belgium
4.3.6   Bulgaria
4.3.7   Croatia
4.3.8   Cyprus
4.3.9   Czech Republic
4.3.10   Denmark
4.3.11   Estonia
4.3.12   Finland
4.3.13   France
4.3.14   Georgia
4.3.15   Germany
4.3.16   Hungary
4.3.17   Iceland
4.3.18   Ireland
4.3.19   Italy
4.3.20   Kazakhstan
4.3.21   Latvia
4.3.22   Lithuania
4.3.23   Malta
4.3.24   Moldova
4.3.25   Netherlands
4.3.26   Norway
4.3.27   Poland
4.3.28   Portugal
4.3.29   Romania
4.3.30   Russia
4.3.31   Slovenia
4.3.32   Spain
4.3.33   Sweden
4.3.34   Switzerland
4.3.35   United Kingdom
4.4   Latin America: Imports in 2004
4.4.1   Executive Summary
4.4.2   Argentina
4.4.3   Bolivia
4.4.4   Brazil
4.4.5   Chile
4.4.6   Colombia
4.4.7   Costa Rica
4.4.8   Ecuador
4.4.9   El Salvador
4.4.10   Guatemala
4.4.11   Honduras
4.4.12   Mexico
4.4.13   Nicaragua
4.4.14   Panama
4.4.15   Paraguay
4.4.16   Peru
4.4.17   Suriname
4.4.18   Uruguay
4.4.19   Venezuela
4.5   N. America & Caribbean: Imports in 2004
4.5.1   Executive Summary
4.5.2   Barbados
4.5.3   Canada
4.5.4   Jamaica
4.5.5   Trinidad and Tobago
4.5.6   United States
4.6   Oceana: Imports in 2004
4.6.1   Executive Summary
4.6.2   Australia
4.6.3   New Zealand
4.7   The Middle East: Imports in 2004
4.7.1   Executive Summary
4.7.2   Armenia
4.7.3   Azerbaijan
4.7.4   Bahrain
4.7.5   Iran
4.7.6   Israel
4.7.7   Jordan
4.7.8   Pakistan
4.7.9   Syrian Arab Republic
4.7.10   Turkey
4.7.11   Turkmenistan
5   DISCLAIMERS, WARRANTEES, AND USER AGREEMENT PROVISIONS
5.1   Disclaimers & Safe Harbor
5.2   ICON Group Ltd. User Agreement Provisions

More Global Vaccines Reports

Human Vaccines by Global Industry Analysts
This report analyzes the worldwide markets for Prophylatic Human Vaccines in US$ Million by the following Product Segments: Pediatric Prophylactic Vaccines and Adult Prophylactic Vaccines. ...

Veterinary Vaccines by Global Industry Analysts
This report analyzes the worldwide markets for Veterinary Vaccines in US$ Million by the following Product Segments - Companion Animal Vaccines (Canine Vaccines, & Feline ...

Influenza Vaccine Market Opportunities and Challenges: Worldwide Forecast by Renub Research
Influenza Vaccine Market Overview Last few years have seen renewed interest in the vaccines market, overcoming the prevailing view that vaccines are a low-margin ...

Liver Disease Treatments: The Global Market by BCC Research
In 2009, the global market for drugs used to treat liver disease was worth approximately $12.4 billion. Sales in 2010 decreased and the market did ...

Global Vaccine Market 2010-2014 by Infiniti Research Limited
TechNavio's analysts forecast the Global Vaccine market to grow at a CAGR of 9.8 percent over the period 2010-2014. One of the key factors contributing ...

See all reports like this >>

The World Market for Vaccines, Antisera, and Other Blood Fractions: A 2004 Global Trade Perspective

Share this report

Other tasks

Research Assistance

Related Markets

Vaccines Reports

Free Alert Me service